Clinical Trial Update: A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments [Phase 2]

View source ↗

Summary

Phase 2 randomized multicenter trial evaluating whether resuming imatinib with atezolizumab improves efficacy versus imatinib alone in unresectable, locally adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Atezolizumab (atezolizumab)
• Imatinib (imatinib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST) | Phase 2 | Status: RECRUITING